188 related articles for article (PubMed ID: 33084880)
1. Rationale and Design of the Genotype-Blinded Trial of Torasemide for the Treatment of Hypertension (BHF UMOD).
McCallum L; Brooksbank K; McConnachie A; Aman A; Lip S; Dawson J; MacIntyre IM; MacDonald TM; Webb DJ; Padmanabhan S
Am J Hypertens; 2021 Feb; 34(1):92-99. PubMed ID: 33084880
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.
Padmanabhan S; Melander O; Johnson T; Di Blasio AM; Lee WK; Gentilini D; Hastie CE; Menni C; Monti MC; Delles C; Laing S; Corso B; Navis G; Kwakernaak AJ; van der Harst P; Bochud M; Maillard M; Burnier M; Hedner T; Kjeldsen S; Wahlstrand B; Sjögren M; Fava C; Montagnana M; Danese E; Torffvit O; Hedblad B; Snieder H; Connell JM; Brown M; Samani NJ; Farrall M; Cesana G; Mancia G; Signorini S; Grassi G; Eyheramendy S; Wichmann HE; Laan M; Strachan DP; Sever P; Shields DC; Stanton A; Vollenweider P; Teumer A; Völzke H; Rettig R; Newton-Cheh C; Arora P; Zhang F; Soranzo N; Spector TD; Lucas G; Kathiresan S; Siscovick DS; Luan J; Loos RJ; Wareham NJ; Penninx BW; Nolte IM; McBride M; Miller WH; Nicklin SA; Baker AH; Graham D; McDonald RA; Pell JP; Sattar N; Welsh P; ; Munroe P; Caulfield MJ; Zanchetti A; Dominiczak AF
PLoS Genet; 2010 Oct; 6(10):e1001177. PubMed ID: 21082022
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure-lowering efficacy of loop diuretics for primary hypertension.
Musini VM; Rezapour P; Wright JM; Bassett K; Jauca CD
Cochrane Database Syst Rev; 2015 May; 2015(5):CD003825. PubMed ID: 26000442
[TBL] [Abstract][Full Text] [Related]
4. Tamm-Horsfall protein/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia.
Liu Y; Goldfarb DS; El-Achkar TM; Lieske JC; Wu XR
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1062-F1076. PubMed ID: 29357410
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering efficacy of loop diuretics for primary hypertension.
Musini VM; Wright JM; Bassett K; Jauca CD
Cochrane Database Syst Rev; 2009 Oct; (4):CD003825. PubMed ID: 19821314
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure lowering efficacy of loop diuretics for primary hypertension.
Musini VM; Rezapour P; Wright JM; Bassett K; Jauca CD
Cochrane Database Syst Rev; 2012 Aug; (8):CD003825. PubMed ID: 22895937
[TBL] [Abstract][Full Text] [Related]
7. Torasemide prolonged release.
Lyseng-Williamson KA
Drugs; 2009 Jul; 69(10):1363-72. PubMed ID: 19583454
[TBL] [Abstract][Full Text] [Related]
8. Validation of uromodulin as a candidate gene for human essential hypertension.
Graham LA; Padmanabhan S; Fraser NJ; Kumar S; Bates JM; Raffi HS; Welsh P; Beattie W; Hao S; Leh S; Hultstrom M; Ferreri NR; Dominiczak AF; Graham D; McBride MW
Hypertension; 2014 Mar; 63(3):551-8. PubMed ID: 24324041
[TBL] [Abstract][Full Text] [Related]
9. Uromodulin: from monogenic to multifactorial diseases.
Scolari F; Izzi C; Ghiggeri GM
Nephrol Dial Transplant; 2015 Aug; 30(8):1250-6. PubMed ID: 25228753
[TBL] [Abstract][Full Text] [Related]
10. Uromodulin is expressed in the distal convoluted tubule, where it is critical for regulation of the sodium chloride cotransporter NCC.
Tokonami N; Takata T; Beyeler J; Ehrbar I; Yoshifuji A; Christensen EI; Loffing J; Devuyst O; Olinger EG
Kidney Int; 2018 Oct; 94(4):701-715. PubMed ID: 30007527
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.
Chen JM; Heran BS; Wright JM
Cochrane Database Syst Rev; 2009 Oct; (4):CD007187. PubMed ID: 19821398
[TBL] [Abstract][Full Text] [Related]
12. Salt stress in the renal tubules is linked to TAL-specific expression of uromodulin and an upregulation of heat shock genes.
Graham LA; Aman A; Campbell DD; Augley J; Graham D; McBride MW; Fraser NJ; Ferreri NR; Dominiczak AF; Padmanabhan S
Physiol Genomics; 2018 Nov; 50(11):964-972. PubMed ID: 30216136
[TBL] [Abstract][Full Text] [Related]
13. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.
Trudu M; Janas S; Lanzani C; Debaix H; Schaeffer C; Ikehata M; Citterio L; Demaretz S; Trevisani F; Ristagno G; Glaudemans B; Laghmani K; Dell'Antonio G; ; Loffing J; Rastaldi MP; Manunta P; Devuyst O; Rampoldi L
Nat Med; 2013 Dec; 19(12):1655-60. PubMed ID: 24185693
[TBL] [Abstract][Full Text] [Related]
14. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
[TBL] [Abstract][Full Text] [Related]
15. Common variants of the UMOD promoter associated with blood pressure in a community-based Chinese cohort.
Han J; Chen Y; Liu Y; Liang Y; Wang X; Liu L; Wang F; Zhang L; Zhang H; Wang H
Hypertens Res; 2012 Jul; 35(7):769-74. PubMed ID: 22592667
[TBL] [Abstract][Full Text] [Related]
16. Role of Uromodulin in Salt-Sensitive Hypertension.
Mary S; Boder P; Padmanabhan S; McBride MW; Graham D; Delles C; Dominiczak AF
Hypertension; 2022 Nov; 79(11):2419-2429. PubMed ID: 36378920
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
[TBL] [Abstract][Full Text] [Related]
18. Na+-K+-2Cl- cotransporter type 2 trafficking and activity: the role of interacting proteins.
Carmosino M; Procino G; Svelto M
Biol Cell; 2012 Apr; 104(4):201-12. PubMed ID: 22211456
[TBL] [Abstract][Full Text] [Related]
19. Urinary Uromodulin Levels and
Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
Int J Nephrol; 2019; 2019():8094049. PubMed ID: 31065383
[TBL] [Abstract][Full Text] [Related]
20. Uromodulin associates with cardiorenal function in patients with hypertension and cardiovascular disease.
Algharably EAH; Bolbrinker J; Lezius S; Reibis R; Wegscheider K; Völler H; Kreutz R
J Hypertens; 2017 Oct; 35(10):2053-2058. PubMed ID: 28598953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
